Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy

Combination therapy

US Patent 10195208 · Granted Feb 5, 2019

Estimated economic value: $17,529,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Determining device context2025
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
Pharmaceutical combination comprising TNO155 and ribociclib2025
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)2024
Anti-CCR7 antibody drug conjugates2024
Pharmaceutical combination comprising an ALK inhibitor and a SHP2 inhibitor2024
Compounds and compositions for treating solid tumors by intratumoral administrat2023
Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)2023
Anti-CCR7 antibody drug conjugates2023
Methods of treating chronic lymphocytic leukemia using 2-(2,6-dioxopiperidin-3-y2023
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2023
Tableware bag2022